Related Experiment Video
Updated: May 28, 2026
06:03
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
POU6F1 Expression Predicts Favorable Prognosis in Lung Adenocarcinoma: Validation Using Patient Cohort and TCGA Data
Mincheol Chae1, Jae-Ho Lee2, Hyowon Hong2
1Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu 42403, Republic of Korea.
Current Issues in Molecular Biology
|May 27, 2026
Summary
High POU6F1 expression in non-small cell lung cancer (NSCLC) correlates with better survival, especially in lung adenocarcinoma (AD). This suggests POU6F1 may be a useful prognostic biomarker for NSCLC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality globally.
- Lung adenocarcinoma (AD) and lung squamous cell carcinoma (SCC) are major subtypes with distinct molecular profiles.
- The clinical significance of POU domain class 6 transcription factor 1 (POU6F1) in NSCLC is not well-understood.
Purpose of the Study:
- To investigate the clinicopathological and prognostic significance of POU6F1 mRNA expression in NSCLC.
- To determine if POU6F1 expression can serve as a prognostic biomarker in NSCLC, particularly in AD.
- To validate findings using The Cancer Genome Atlas (TCGA) datasets.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) to measure POU6F1 mRNA expression in 153 NSCLC tumor tissues.
- Statistical analysis to correlate POU6F1 expression with clinicopathological characteristics.
- Survival analysis (including multivariate Cox regression) and TCGA data analysis to assess prognostic value.
Main Results:
- High POU6F1 expression was found in 31.4% of NSCLC patients.
- Elevated POU6F1 expression was significantly associated with younger age, female sex, non-smoking status, AD histology, and EGFR mutations.
- High POU6F1 expression correlated with improved overall survival in NSCLC patients, particularly in AD, and was an independent prognostic factor.
Conclusions:
- POU6F1 mRNA expression is significantly associated with favorable clinicopathological features and improved survival in NSCLC, especially in lung adenocarcinoma.
- POU6F1 may serve as a potential prognostic biomarker for NSCLC, particularly AD.
- Further research is needed to validate these findings at the protein level and explore underlying mechanisms.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...